# Michael Hill

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-hill/

## Facts

| Field | Value |
| --- | --- |
| Citations | 14,368 |
| Field | Cardiac pacing and defibrillation studies |
| h-index | 49 |
| i10-index | 102 |
| Last Known Institution | University of Oxford |
| OpenAlex ID | https://openalex.org/A5001872209 |
| ORCID iD | 0000-0002-3861-6105 |
| Works | 185 |

## Researcher papers

- [The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial](https://scholariq.org/papers/the-effects-of-lowering-ldl-cholesterol-with-simvastatin-plus-ezetimibe-in/)
- [Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure](https://scholariq.org/papers/effect-of-cardiac-resynchronization-therapy-on-left-ventricular-size-and/)
- [Tissue Doppler Echocardiographic Evidence of Reverse Remodeling and Improved Synchronicity by Simultaneously Delaying Regional Contraction After Biventricular Pacing Therapy in Heart Failure](https://scholariq.org/papers/tissue-doppler-echocardiographic-evidence-of-reverse-remodeling-and-improved/)
- [A genome-wide search for quantitative trait loci underlying asthma](https://scholariq.org/papers/a-genome-wide-search-for-quantitative-trait-loci-underlying-asthma/)
- [HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment](https://scholariq.org/papers/hps2-thrive-randomized-placebo-controlled-trial-in-25-673-high-risk-patients-of/)
- [Stroke genetics informs drug discovery and risk prediction across ancestries](https://scholariq.org/papers/stroke-genetics-informs-drug-discovery-and-risk-prediction-across-ancestries/)
- [Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke](https://scholariq.org/papers/lipids-lipoproteins-and-metabolites-and-risk-of-myocardial-infarction-and-stroke/)
- [Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults](https://scholariq.org/papers/causal-associations-of-blood-lipids-with-risk-of-ischemic-stroke-and/)
- [Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing](https://scholariq.org/papers/prevention-of-recurrent-atrial-fibrillation-with-chronic-dual-site-right-atrial/)
- [Perioperative Rosuvastatin in Cardiac Surgery](https://scholariq.org/papers/perioperative-rosuvastatin-in-cardiac-surgery/)
- [Cardiac Resynchronization Therapy Improves Renal Function in Human Heart Failure With Reduced Glomerular Filtration Rate](https://scholariq.org/papers/cardiac-resynchronization-therapy-improves-renal-function-in-human-heart-failure/)

## Researcher topics

- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Genetic Associations and Epidemiology](https://scholariq.org/topics/genetic-associations-and-epidemiology/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)

## Researcher university

- [University of Oxford](https://scholariq.org/institutions/university-of-oxford/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.